Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Search Result
Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients
Apply
Soquelitinib
Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step